Prolymphocytic Leukemia is a rare form of chronic lymphoproliferative disorder. There are two distinct types of Prolymphocytic Leukemia, B Cell and T Cell. T Cell is very aggressive and tends to have poor response to chemotherapy. If remission is reached, most will only last a few months with T Cell Prolymphocytic Leukemia. In B-Cell Prolymphocytic Leukemia, remission is more feasible and may be completely progression free but the prognosis is still poor. B-Cell has been associated with deletions on chromosome 11 and 13.
Prolymphocytic Leukemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Prolymphocytic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 3850 products for the study of Prolymphocytic Leukemia that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.